Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–16 of 16 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04329494
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Appendiceal Neoplasms, +62 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Northwell Health Cancer Institute at Huntington Greenlawn, New York, United States
NCT05092373
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04811703
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +30 more
- Locations
-
- Hôpital Claude Huriez - Chirurgie générale et digestive Lille, France
- Hôpital Claude Huriez - Oncologie médicale Lille, France
- Hôpital de la Croix-Rousse Lyon, France
- Hôpital Lyon Sud - Chirurgie Digestive et Oncologique Pierre-Bénite, France
NCT06586957
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
- Locations
-
- University of Arkansas Medical School Little Rock, Arkansas, United States
- University of California - Los Angeles Los Angeles, California, United States
- UCSF San Francisco, California, United States
- SCRI at HealthOne Denver, Colorado, United States
NCT05759923
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Colorectal Carcinoma, +41 more
- Locations
-
- Site Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
- Site Otwock, Masovian Voivodeship, Poland
- SIte Warsaw, Masovian Voivodeship, Poland
NCT05733000
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Not Yet Recruiting
Prediction of Ovarian Cancer Histotypes and Surgical Outcome
NCT07057167
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
Not specified
NCT03508570
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +58 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04703920
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
Active, Not Recruiting
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
NCT02298959
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
- Locations
-
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
Active, Not Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
NCT04550494
- Conditions
- Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
- Locations
-
- UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
Active, Not Recruiting
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
NCT02650986
- Conditions
- Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +78 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02627443
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +26 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
Active, Not Recruiting
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
NCT05075993
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
NCT04514484
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
NCT04673448
- Conditions
- Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +53 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States